PT
REGN icon

Plimoth Trust’s Regeneron Pharmaceuticals REGN Stock Holding History

Plimoth Trust’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$396K Hold
513
– – 0.09% 131
2025
Q4 		$396K Sell
513
-48
-9% -$32.6K 0.09% 130
2025
Q3 		$315K Sell
561
-227
-29% -$128K 0.07% 146
2025
Q2 		$414K Sell
788
-19
-2% -$10.6K 0.1% 125
2025
Q1 		$512K Sell
807
-30
-4% -$20.6K 0.13% 117
2024
Q4 		$596K Hold
837
– – 0.15% 108
2024
Q3 		$880K Sell
837
-71
-8% -$79K 0.22% 95
2024
Q2 		$954K Sell
908
-60
-6% -$58.2K 0.25% 85
2024
Q1 		$932K Sell
968
-164
-14% -$156K 0.25% 86
2023
Q4 		$994K Sell
1,132
-1,324
-54% -$1.09M 0.29% 81
2023
Q3 		$2.02M Sell
2,456
-188
-7% -$148K 0.63% 56
2023
Q2 		$1.9M Sell
2,644
-19
-0.7% -$14.6K 0.57% 60
2023
Q1 		$2.19M Buy
2,663
+40
+2% +$30.2K 0.68% 56
2022
Q4 		$1.89M Sell
2,623
-75
-3% -$55.3K 0.61% 59
2022
Q3 		$1.86M Buy
2,698
+206
+8% +$130K 0.64% 55
2022
Q2 		$1.47M Buy
2,492
+442
+22% +$287K 0.46% 70
2022
Q1 		$1.43M Buy
2,050
+13
+0.6% +$8.22K 0.38% 76
2021
Q4 		$1.29M Buy
2,037
+326
+19% +$200K 0.33% 85
2021
Q3 		$1.04M Buy
1,711
+199
+13% +$124K 0.29% 91
2021
Q2 		$844K Buy
+1,512
New +$766K 0.24% 100

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Plimoth Trust's REGN Position: Q1 2026 in Review

Plimoth Trust held its Regeneron Pharmaceuticals (REGN) position steady in Q1 2026 at 513 shares worth $396K. The position accounts for 0.09% of the portfolio, ranked #131.

Plimoth Trust first reported a position in REGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $2.19M in Q1 2023. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Plimoth Trust held 513 shares of Regeneron Pharmaceuticals worth $396K as of Q1 2026.
  • Plimoth Trust left its Regeneron Pharmaceuticals share count unchanged in Q1 2026.
  • Regeneron Pharmaceuticals made up 0.09% of Plimoth Trust's portfolio in Q1 2026, its #131 holding.
  • Plimoth Trust first reported a position in Regeneron Pharmaceuticals in Q2 2021 and has held it in 20 quarters since.
  • Plimoth Trust's Regeneron Pharmaceuticals position peaked at $2.19M in Q1 2023.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Plimoth Trust's 13F filing for Q1 2026, filed 27 Apr 2026.